Tags

Type your tag names separated by a space and hit enter

Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Am J Hematol. 2021 09 01; 96(9):E321-E324.AJ

Authors+Show Affiliations

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Pub Type(s)

Letter

Language

eng

PubMed ID

34028867

Citation

Terpos, Evangelos, et al. "Comparison of Neutralizing Antibody Responses Against SARS-CoV-2 in Healthy Volunteers Who Received the BNT162b2 mRNA or the AZD1222 Vaccine: Should the Second AZD1222 Vaccine Dose Be Given Earlier?" American Journal of Hematology, vol. 96, no. 9, 2021, pp. E321-E324.
Terpos E, Trougakos IP, Karalis V, et al. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? Am J Hematol. 2021;96(9):E321-E324.
Terpos, E., Trougakos, I. P., Karalis, V., Ntanasis-Stathopoulos, I., Sklirou, A. D., Bagratuni, T., Papanagnou, E. D., Patseas, D., Gumeni, S., Malandrakis, P., Korompoki, E., & Dimopoulos, M. A. (2021). Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? American Journal of Hematology, 96(9), E321-E324. https://doi.org/10.1002/ajh.26248
Terpos E, et al. Comparison of Neutralizing Antibody Responses Against SARS-CoV-2 in Healthy Volunteers Who Received the BNT162b2 mRNA or the AZD1222 Vaccine: Should the Second AZD1222 Vaccine Dose Be Given Earlier. Am J Hematol. 2021 09 1;96(9):E321-E324. PubMed PMID: 34028867.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? AU - Terpos,Evangelos, AU - Trougakos,Ioannis P, AU - Karalis,Vangelis, AU - Ntanasis-Stathopoulos,Ioannis, AU - Sklirou,Aimilia D, AU - Bagratuni,Tina, AU - Papanagnou,Eleni-Dimitra, AU - Patseas,Dimitrios, AU - Gumeni,Sentiljana, AU - Malandrakis,Panagiotis, AU - Korompoki,Eleni, AU - Dimopoulos,Meletios A, Y1 - 2021/06/02/ PY - 2021/05/15/received PY - 2021/05/17/accepted PY - 2021/5/25/pubmed PY - 2021/8/24/medline PY - 2021/5/24/entrez SP - E321 EP - E324 JF - American journal of hematology JO - Am J Hematol VL - 96 IS - 9 SN - 1096-8652 UR - https://www.unboundmedicine.com/medline/citation/34028867/Comparison_of_neutralizing_antibody_responses_against_SARS_CoV_2_in_healthy_volunteers_who_received_the_BNT162b2_mRNA_or_the_AZD1222_vaccine:_Should_the_second_AZD1222_vaccine_dose_be_given_earlier DB - PRIME DP - Unbound Medicine ER -